Skip to main content
. Author manuscript; available in PMC: 2023 May 2.
Published in final edited form as: Mol Pharm. 2022 Apr 11;19(5):1378–1388. doi: 10.1021/acs.molpharmaceut.1c00924

Figure 3.

Figure 3.

Cytosolic delivery of HiBit by CPP12 and CPP12-2 and complementation with transiently expressed LgBit in HEK293T cells in the presence of 1% FBS. Data shown represent the mean ± SD of multiple independent experiments (n = 3 for HiBit and n = 7 for CPP12-HiBit and CPP12-2-HiBit. *, p ≤ 0.05.